As U.S. Covid-19 cases break records, weekly deaths rise 3%
Leaders face ‘critical moment’ as Covid cases spike, says WHO chief
Covid-19 roundup: Russian biotech seeks permission to produce remdesivir generic; Why did BARDA fund plasma company part-owned by Rick Santorum?
Futures Soar In Rollercoaster Session As "Huge Week" Begins
WHO's Tedros Self-Quarantines After COVID-19 Exposure
Is China An Existential Threat To America?
BoJo Weighs 1-Month COVID-19 Lockdown, US Breaks Global Record For Daily Cases: Live Updates
Indian pharma is being squeezed – and it's bad news for drug access in developing countries
WHO Special Envoy On COVID Reiterates Caution Against Lockdowns As Primary Virus Plan
Healthcare And Biotech Outlook –Final Quarter of 2020
What could the spring 2021 housing market have in store?
Moderna on track to report late-stage Covid-19 vaccine data
Escaping the ‘Era of Pandemics’: experts warn worse crises to come; offer options to reduce risk
Remdesivir for COVID-19: FDA approved but still unproven
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday
Miniature organs help test potential coronavirus drugs; GI symptoms linked to severe Covid-19
Gilead cuts 2020 sales outlook as Covid-19 drug remdesivir falls short
Sanofi, GSK to supply vaccine doses to WHO-backed alliance
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday;
Covid-19 roundup: Novavax delays PhIII trial in US, with PhII data coming Friday; CBER director promises 'safe and effective' vaccine in op-ed
Sanofi, GSK Ink Covax Supply Deal For 200M Covid Vaccine Doses
Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot
Strong Rebound Expected For This Week’s US Q3 GDP Report
"Tremendous News!" - Maduro Touts Venezuelan Vaccine That Inhibits COVID
Good Entry Point for Gilead Sciences (GILD)? Not Just Yet, Says Analyst
Weekly U.S. Covid-19 deaths up 15%, new cases rise 24%
Euro Falls on Rising Eurozone COVID-19 Cases, Risk-Off Sentiment
Futures Tumble, European Tech Stocks Plunge Amid Surging Virus Cases, Reflation Trade Fears
Eliminating COVID-19: What the world can learn from NZ and Taiwan
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval